Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00617916Completed

Hyperspectral Imaging to Assess and Predict Diabetic Foot Ulcers

Role: lead

NCT00767923Unknown

Validation of OxyVu for Assessing Level of Amputation With Comparison to Other Modalities

Role: lead

NCT00768027Suspended

Outcome Assessment in Patients Treated With Hyperbaric Oxygen Using OxyVu Tissue Oxygenation Monitoring System

Role: lead

NCT00768495Unknown

Hyperspectral Imaging Pre and Post Endovascular Intervention

Role: lead

All 4 trials loaded